MYDA Advisors’s SurgePays SURG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-72,000
Closed -$277K 161
2024
Q1
$277K Sell
72,000
-64,540
-47% -$430K 0.08% 98
2023
Q4
$881K Sell
136,540
-107,727
-44% -$574K 0.29% 56
2023
Q3
$1.14M Sell
244,267
-54,000
-18% -$280K 0.37% 51
2023
Q2
$2.18M Sell
298,267
-22,000
-7% -$131K 0.65% 46
2023
Q1
$1.44M Sell
320,267
-138,400
-30% -$747K 0.55% 46
2022
Q4
$3.01M Buy
+458,667
New +$2.77M 1.85% 22

Other funds holding SURG

MYDA Advisors's SURG Position: Q2 2024 in Review

MYDA Advisors sold out of SurgePays (SURG) in Q2 2024, closing a stake of 72,000 shares — an estimated $277K sold.

MYDA Advisors first reported a position in SURG in Q4 2022 and held it in 6 quarters. The position peaked at $3.01M in Q4 2022. 32 funds tracked by Wall St. Rank hold SURG as of Q2 2024.

  • MYDA Advisors reported no remaining SurgePays position as of Q2 2024 after selling out during the quarter.
  • MYDA Advisors sold 72,000 SurgePays shares in Q2 2024, an estimated $277K.
  • MYDA Advisors first reported a position in SurgePays in Q4 2022 and held it in 6 quarters.
  • MYDA Advisors's SurgePays position peaked at $3.01M in Q4 2022.
  • 32 funds tracked by Wall St. Rank held SurgePays as of Q2 2024.

Based on MYDA Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.